Immune thrombocytopenia (ITP) trials in Greece

5 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  Where

  Patras, Thessaloniki

  Age

  18 years and over

  People

  171 worldwide

  Run by

  Takeda

  See details and how to joinNCT06722235 · EU 2024-514401-54-00
• Phase 3Taking people
  A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  Where

  Patras, Thessaloniki

  Age

  18 years and over

  People

  150 worldwide

  Run by

  Takeda

  See details and how to joinNCT06948318 · EU 2025-521692-31-00
• Phase 2Taking people
  Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia

  Where

  Patra, Thessaloniki

  Age

  18 years to 80 years

  People

  30 worldwide

  Run by

  Nuvig Therapeutics, Inc.

  See details and how to joinNCT07095127 · EU 2024-520359-26-00
• Phase 1/2Taking people
  A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

  Where

  Athens, Chaïdári, Ioannina, Thessaloniki

  Age

  18 years and over

  People

  24 worldwide

  Run by

  Climb Bio, Inc.

  See details and how to joinNCT07043946
• Phase 2Not yet taking people in Greece
  A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY

  Where

  Athens, Thessaloniki

  Age

  18 years and over

  People

  14

  Run by

  Hellenic Society of Hematology

  See details and how to joinNCT07019545 · EU 2023-509131-12-01